Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an in silico study for drug development P Pandey, JS Rane, A Chatterjee, A Kumar, R Khan, A Prakash, S Ray Journal of biomolecular Structure and Dynamics 39 (16), 6306-6316, 2021 | 308 | 2021 |
Combating COVID-19 with mesenchymal stem cell therapy K Rajarshi, A Chatterjee, S Ray Biotechnology reports 26, e00467, 2020 | 99 | 2020 |
Combining SARS-CoV-2 proofreading exonuclease and RNA-dependent RNA polymerase inhibitors as a strategy to combat COVID-19: a high-throughput in silico screening S Khater, P Kumar, N Dasgupta, G Das, S Ray, A Prakash Frontiers in microbiology 12, 647693, 2021 | 56 | 2021 |
Nucleic acid-based therapy for coronavirus disease 2019 R Piyush, K Rajarshi, A Chatterjee, R Khan, S Ray Heliyon 6 (9), 2020 | 42 | 2020 |
Essential functional molecules associated with SARS-CoV-2 infection: Potential therapeutic targets for COVID-19 K Rajarshi, R Khan, MK Singh, T Ranjan, S Ray, S Ray Gene 768, 145313, 2021 | 32 | 2021 |
BCG vaccination strategy implemented to reduce the impact of COVID-19: Hype or Hope? K Rajarshi, A Chatterjee, S Ray Medicine in Drug Discovery 7, 100049, 2020 | 30* | 2020 |
Targeting virus–host interaction by novel pyrimidine derivative: an in silico approach towards discovery of potential drug against COVID-19 JS Rane, P Pandey, A Chatterjee, R Khan, A Kumar, A Prakash, S Ray Journal of Biomolecular Structure and Dynamics 39 (15), 5768-5778, 2021 | 28 | 2021 |
Antimicrobial peptide CRAMP (16–33) stalls bacterial cytokinesis by inhibiting FtsZ assembly S Ray, HPS Dhaked, D Panda Biochemistry 53 (41), 6426-6429, 2014 | 28 | 2014 |
BT‐benzo‐29 inhibits bacterial cell proliferation by perturbing FtsZ assembly S Ray, B Jindal, K Kunal, A Surolia, D Panda The FEBS Journal 282 (20), 4015-4033, 2015 | 27 | 2015 |
Convalescent plasma therapy: a promising coronavirus disease 2019 treatment strategy R Piyush, K Rajarshi, R Khan, S Ray Open Biology 10 (9), 200174, 2020 | 23 | 2020 |
GTP regulates the interaction between MciZ and FtsZ: a possible role of MciZ in bacterial cell division S Ray, A Kumar, D Panda Biochemistry 52 (2), 392-401, 2013 | 22 | 2013 |
ZapC promotes assembly and stability of FtsZ filaments by binding at a different site on FtsZ than ZipA A Bhattacharya, S Ray, D Singh, HPS Dhaked, D Panda International journal of biological macromolecules 81, 435-442, 2015 | 16 | 2015 |
Molecular chaperones in protein folding and stress management in cyanobacteria A Chatterjee, K Rajarshi, H Ghosh, MK Singh, OP Roy, S Ray Advances in cyanobacterial biology, 119-128, 2020 | 11 | 2020 |
Regulation of Streptococcus pneumoniae FtsZ assembly by divalent cations: paradoxical effects of Ca2+ on the nucleation and bundling of FtsZ polymers HPS Dhaked, S Ray, RR Battaje, A Banerjee, D Panda The FEBS Journal 286 (18), 3629-3646, 2019 | 11 | 2019 |
Phytochemicals as Anticancer Drugs: Targeting the Microtubular Network of Cancer Cells R Khan, A Chatterjee, H Ghosh, S Kapoor, S Ray Phytochemistry: An in-silico and in-vitro Update, 57-76, 2019 | 4 | 2019 |
Bacterial Cell Division Machinery: An Insight for Development of New Antibacterial Agent R Khan, S Ray Phytochemistry: An in-silico and in-vitro Update, 109-132, 2019 | 2 | 2019 |
Arylcoumarin perturbs SARS-CoV-2 pathogenesis by targeting the S-protein/ACE2 interaction R Singh, A Kumar, JS Rane, R Khan, G Tripathi, AK Ajay, A Prakash, ... Scientific Reports 12 (1), 17038, 2022 | 1 | 2022 |
Gluconeogenesis Regulation, Measurements and Disorders SR LS Rai, A Narayanan Carbohydrate Metabolism: Theory and Practical Approach, 99-113, 2017 | 1 | 2017 |
Alterations in Circadian Rhythms, Sleep, and Physical Activity in COVID-19: Mechanisms, Interventions, and Lessons for the Future S Das, R Khan, S Banerjee, S Ray, S Ray Molecular Neurobiology, 1-23, 2024 | | 2024 |
An Intimate Alliance of DNA-Damage Response Network with Cell-Cycle Checkpoints Amid Events of Uncontrolled Cellular Proliferation: A Mini-Review A Chatterjee, K Rajarshi, R Khan, H Ghosh, S Kapoor, S Ray Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2021 | | 2021 |